Maternal malaria and gravidity interact to modify infant susceptibility to malaria.
about
The impact of maternal malaria on newbornsPlasmodium malaria and antimalarial antibodies in the first year of lifeNon-malaria fevers in a high malaria endemic area of Ghana.Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infectionIntermittent preventive treatment in pregnant women is associated with increased risk of severe malaria in their offspringScheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized ControlHypertension and maternal-fetal conflict during placental malariaImpact of In Utero Exposure to Malaria on Fetal T Cell Immunity.High throughput functional assays of the variant antigen PfEMP1 reveal a single domain in the 3D7 Plasmodium falciparum genome that binds ICAM1 with high affinity and is targeted by naturally acquired neutralizing antibodiesCan prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya.Unraveling the impact of malaria exposure before birthQuantifying the number of pregnancies at risk of malaria in 2007: a demographic studySubmicroscopic and Asymptomatic Congenital Infection by Plasmodium vivax or P. falciparum in Colombia: 37 Cases with Placental Histopathology and Cytokine Profile in Maternal and Placental Blood.Placental malaria is associated with reduced early life weight development of affected children independent of low birth weightParasite burden and severity of malaria in Tanzanian childrenPregnancy-associated malaria and malaria in infants: an old problem with present consequencesA targeted association study of immunity genes and networks suggests novel associations with placental malaria infection.Infections in infants during the first 12 months of life: role of placental malaria and environmental factorsSulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC).Modeling the influence of local environmental factors on malaria transmission in Benin and its implications for cohort study.Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypesCommunity-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health in The Gambia, Burkina Faso and Benin: study protocol for a randomized controlled trialA plasma survey using 38 PfEMP1 domains reveals frequent recognition of the Plasmodium falciparum antigen VAR2CSA among young Tanzanian children.Ancillary-care responsibilities in observational research: two cases, two issuesHierarchical, domain type-specific acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 in Tanzanian children.[Congenital Plasmodium falciparum malaria: epidemiological, clinical, biological, therapeutic and prognostic aspects in Ouagadougou, Burkina Faso]Maternal anaemia at delivery and haemoglobin evolution in children during their first 18 months of life using latent class analysis.Plasmodium falciparum variability and immune evasion proceed from antigenicity of consensus sequences from DBL6ε; generalization to all DBL from VAR2CSA.High plasma levels of HLA-G are associated with low birth weight and with an increased risk of malaria in infancyAssociation of IL-4 and IL-10 maternal haplotypes with immune responses to P. falciparum in mothers and newbornsImpact of malaria at the end of pregnancy on infant mortality and morbidity.Cytokine profiles at birth predict malaria severity during infancy.Impact of pregnancy-associated malaria on infant malaria infection in southern Benin.Cord blood dendritic cell subsets in African newborns exposed to Plasmodium falciparum in uteroEarly home-based recognition of anaemia via general danger signs, in young children, in a malaria endemic community in north-east Tanzania.Placental malaria-associated suppression of parasite-specific immune response in neonates has no major impact on systemic CD4 T cell homeostasis.Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance.Determinants of infant susceptibility to malaria during the first year of life in South Western cameroonPopulation pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.
P2860
Q21032461-633DF038-A363-4AEB-A3E5-BA9C178DA8CDQ26315542-271F0A90-C518-46B4-8EA9-F3ED12F67CA2Q27312253-BB65EBD2-6037-437F-956D-1821ADDF5D19Q27972579-BC9BE37B-5935-4E7A-A6C5-3CE1B584D6E5Q28486791-6581E96B-A167-4530-92A8-4F47A764C178Q28554025-5CF34298-9194-4222-945F-27BAAF760255Q28766797-4CCAB087-33A6-436E-BB02-482CB86C6146Q30245481-426E225A-DAF8-4F94-8072-3EB4D999A9F9Q33432676-D9D26494-9EFF-4BDE-9F03-27E5ACA7ADF7Q33487651-25FEA810-CB99-4743-AE90-AA2A319B20CDQ33487654-AC8F4868-C5C0-478A-BC4D-2AA894808AFFQ33528929-78B58379-2E37-435C-ADBE-F631E53AF819Q33552231-638C6D48-E585-4D2C-80DF-9C328EC0A62FQ33738991-35B8646E-DD34-4DD8-9D8B-2B03CB0DAB3DQ33882158-34827943-E3F7-4F75-8D4E-0E5C94C3300CQ33963392-BC28C08C-2483-4E9A-9771-E2D4BD553B39Q34031788-C32A4E6D-4B93-45BB-80D5-25E6B4C4425BQ34077950-B21DB0A9-753F-45CF-99E8-194D0B182D8BQ34115647-D425BB35-F68A-4F54-A3CD-372AC3331DDFQ34124974-43042AC6-9F88-46B3-9A76-7598EBFD57C1Q34129908-DA1F5B1A-31B3-44D8-8748-28204F0F18DFQ34143715-E156573D-DBCD-4D54-A1F7-0C630BCF87FBQ34147732-BEF0B180-686F-45FE-8B19-7208482C7514Q34154566-A74767BE-C37B-43D4-B569-72DC0715D0D9Q34290645-5EA962E4-313A-45B4-B5B8-9C3CBEA1C99AQ34431668-D49CB4EE-E369-473C-95CD-992C4AC7C6D2Q34491087-DA2444BE-16F0-44D9-B90E-AF092E04501CQ34571421-4F2E3CB7-243E-463B-B68A-188F315FE734Q34591148-BABA8C28-3281-4F43-B3BE-6736D283264FQ34719080-0362AEC9-58D2-4FD3-BD91-0D38364D4B1EQ34764578-93B87F9C-BAF1-4C69-8A3F-9AA66031086DQ35018777-95C44068-5911-4CA5-AD04-A1FC53731BE9Q35043984-AD1265A4-0B13-41D9-AE3A-C8E3BCAAE8D0Q35073890-9A405FBB-9CCF-4636-8012-12F76D208491Q35185526-946D72FD-2A1B-42A8-841C-7A6DB19CFAB9Q35328744-87F6FAC3-A11E-4D2D-9AF4-19BB9D1D46BDQ35356543-14CE1CB0-8EEF-48DA-A9FE-DC2004D8A689Q35452357-C018ECC3-854D-4BC7-89D3-33F23BF943BDQ35628255-92DA0D4C-84A1-4DB8-97AB-A409344A3AFFQ35746240-96A253F7-2875-4002-9B23-46B9B7A2C201
P2860
Maternal malaria and gravidity interact to modify infant susceptibility to malaria.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Maternal malaria and gravidity interact to modify infant susceptibility to malaria
@nl
Maternal malaria and gravidity interact to modify infant susceptibility to malaria.
@ast
Maternal malaria and gravidity interact to modify infant susceptibility to malaria.
@en
type
label
Maternal malaria and gravidity interact to modify infant susceptibility to malaria
@nl
Maternal malaria and gravidity interact to modify infant susceptibility to malaria.
@ast
Maternal malaria and gravidity interact to modify infant susceptibility to malaria.
@en
prefLabel
Maternal malaria and gravidity interact to modify infant susceptibility to malaria
@nl
Maternal malaria and gravidity interact to modify infant susceptibility to malaria.
@ast
Maternal malaria and gravidity interact to modify infant susceptibility to malaria.
@en
P2093
P2860
P3181
P1433
P1476
Maternal malaria and gravidity interact to modify infant susceptibility to malaria.
@en
P2093
Gonzalo J Domingo
Jin-Long Li
Melissa C Bolla
Michal Fried
Theonest K Mutabingwa
Xiaohong Li
P2860
P3181
P356
10.1371/JOURNAL.PMED.0020407
P407
P577
2005-11-08T00:00:00Z